Product
Nanoparticle Albumin-bound Paclitaxel
1 clinical trial
2 indications
Indication
Triple-Negative Breast CancerIndication
Ovarian CancerClinical trial
A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Breast or Gynecologic MalignanciesStatus: Completed, Estimated PCD: 2021-07-01